All Stories

  1. Gene Therapy for Glomerular Disease
  2. Response to First Course of Intensified Immunosuppression in Genetically Stratified Steroid Resistant Nephrotic Syndrome
  3. Podocyte RhoGTPases: new therapeutic targets for nephrotic syndrome?
  4. Recent advances in understanding and treating nephrotic syndrome
  5. MAGI2 Mutations Cause Congenital Nephrotic Syndrome
  6. Cell biology and genetics of minimal change disease
  7. Unilateral hypoplastic kidney - a novel highly penetrant feature of familial juvenile hyperuricaemic nephropathy
  8. Short course daily prednisolone therapy during an upper respiratory tract infection in children with relapsing steroid-sensitive nephrotic syndrome (PREDNOS 2): protocol for a randomised controlled trial
  9. A118: Laboratory Investigation of the Role of Toll‐Like Receptors on Kidney Cells in Pathogenesis of Lupus Nephritis
  10. Sialic acid attenuates puromycin aminonucleoside-induced desialylation and oxidative stress in human podocytes
  11. The cytoprotective role of autophagy in puromycin aminonucleoside treated human podocytes
  12. NPHS2Mutations in Steroid-Resistant Nephrotic Syndrome: A Mutation Update and the Associated Phenotypic Spectrum
  13. ADCK4 mutations promote steroid-resistant nephrotic syndrome through CoQ10 biosynthesis disruption
  14. Proteinuria in Preeclampsia from a Podocyte Injury Perspective
  15. Rapamycin-induced modulation of miRNA expression is associated with amelioration of HIV-associated nephropathy (HIVAN)
  16. Current evidence for the role of complement in the pathogenesis of Shiga toxin haemolytic uraemic syndrome
  17. Serum from minimal change patients in relapse increases CD80 expression in cultured podocytes
  18. Dysregulated Autophagy Contributes to Podocyte Damage in Fabry’s Disease
  19. Morphine Induces Albuminuria by Compromising Podocyte Integrity
  20. Active proteases in nephrotic plasma lead to a podocin‐dependent phosphorylation of VASP in podocytes via protease activated receptor‐1
  21. Protective Effects of the mTOR Inhibitor Everolimus on Cytoskeletal Injury in Human Podocytes Are Mediated by RhoA Signaling
  22. Renal hypertension: an unusual cause for a common problem
  23. Rapamycin-induced modulation of HIV gene transcription attenuates progression of HIVAN
  24. Nef interaction with actin compromises human podocyte actin cytoskeletal integrity
  25. Proteolytic Enzymes as Biomarkers of Focal Segmental Glomerulosclerosis
  26. Genetics of steroid resistant nephrotic syndrome
  27. LPS and PAN-induced podocyte injury in an in vitro model of minimal change disease: changes in TLR profile
  28. VEGF-A regulates glomerular endothelial cell expression of protective complement regulators involved in the pathogenesis of atypical haemolytic uraemic syndrome
  29. Chronic exposure to laminar shear stress induces Kruppel-like factor 2 in glomerular endothelial cells and modulates interactions with co-cultured podocytes
  30. Podocyte culture: Tricks of the trade
  31. The phenomenon of focal segmental glomerulosclerosis post-transplantation—a one-hit wonder?
  32. New developments in steroid-resistant nephrotic syndrome
  33. Current concepts of the podocyte in nephrotic syndrome
  34. Exogenous vascular endothelial growth factor supplementation can restore the podocyte barrier‐forming capacity disrupted by sera of preeclamptic women
  35. IQGAP1 Interacts with Components of the Slit Diaphragm Complex in Podocytes and Is Involved in Podocyte Migration and Permeability In Vitro
  36. HSP27/HSPB1 as an adaptive podocyte antiapoptotic protein activated by high glucose and angiotensin II
  37. WT1 Mutants Reveal SRPK1 to Be a Downstream Angiogenesis Target by Altering VEGF Splicing
  38. The podocyte cytoskeleton—key to a functioning glomerulus in health and disease
  39. Receptor-Mediated Endocytosis of α-Galactosidase A in Human Podocytes in Fabry Disease
  40. Monocyte- and Endothelial-Derived Microparticles Induce an Inflammatory Phenotype in Human Podocytes
  41. Circulating urokinase receptor as a cause of focal segmental glomerulosclerosis
  42. An In Vitro Model of the Glomerular Capillary Wall Using Electrospun Collagen Nanofibres in a Bioartificial Composite Basement Membrane
  43. Podocytes as a Target of Insulin
  44. Intrinsic renal cell and leukocyte-derived TLR4 aggravate experimental anti-MPO glomerulonephritis
  45. Genetics in Clinical Practice: Nephrotic and Proteinuric Syndromes
  46. Lipid phosphatase SHIP2 downregulates insulin signalling in podocytes
  47. Insulin Signaling to the Glomerular Podocyte Is Critical for Normal Kidney Function
  48. Functional distinctions in cytosolic calcium regulation between cells of the glomerular filtration barrier
  49. Hepatocyte growth factor signaling ameliorates podocyte injury and proteinuria
  50. Urinary excretion of IGFBP-1 and -3 correlates with disease activity and differentiates focal segmental glomerulosclerosis and minimal change disease
  51. Glomerular Disturbances in Preeclampsia: Disruption Between Glomerular Endothelium and Podocyte Symbiosis
  52. Middle-term use of Cinacalcet in paediatric dialysis patients
  53. Nephrin—signature molecule of the glomerular podocyte?
  54. Novel conditionally immortalized human proximal tubule cell line expressing functional influx and efflux transporters
  55. Regulation of Neph3 gene in podocytes – key roles of transcription factors NF-κB and Sp1
  56. TNF-like weak inducer of apoptosis (TWEAK) induces inflammatory and proliferative effects in human kidney cells
  57. Flufenamic acid is a tool for investigating TRPC6-mediated calcium signalling in human conditionally immortalised podocytes and HEK293 cells
  58. Glomerular Disturbances in Preeclampsia: Disruption Between Glomerular Endothelium and Podocyte Symbiosis
  59. Multicentre prospective randomised trial of tacrolimus, azathioprine and prednisolone with or without basiliximab: two-year follow-up data
  60. Preeclamptic Sera Directly Induce Slit-Diaphragm Protein Redistribution and Alter Podocyte Barrier-Forming Capacity
  61. Podocytes express ADAMTS13 in normal renal cortex and in patients with thrombotic thrombocytopenic purpura
  62. Sirolimus Toxicity and Vascular Endothelial Growth Factor Release From Islet and Renal Cell Lines
  63. Identification of the Glomerular Podocyte as a Target for Growth Hormone Action
  64. A proteomic investigation of glomerular podocytes from a Denys‐Drash Syndrome patient with a mutation in the Wilms tumour suppressor gene WT1
  65. The Bioactivity of Plasma Factors in Focal Segmental Glomerulosclerosis
  66. PPARα activation upregulates nephrin expression in human embryonic kidney epithelial cells and podocytes by a dual mechanism
  67. Biology of the Human Podocyte
  68. Urine – A Mirror of the (Glomerular) Soul?
  69. Co-Localization of Nephrin, Podocin, and the Actin Cytoskeleton
  70. Podocin, a raft-associated component of the glomerular slit diaphragm, interacts with CD2AP and nephrin
  71. Podocin, a raft-associated component of the glomerular slit diaphragm, interacts with CD2AP and nephrin
  72. Treatment of severe complicated Kawasaki disease with oral prednisolone and aspirin
  74. Attempts to demonstrate indirect T cell allorecognition of donor MHC peptides in transplant patients
  75. Hypercalciuria and ultrasound abnormalities in children with cystinosis
  76. Renal parenchymal malakoplakia ?a case report and review of the literature
  77. Results of balloon pulmonary valvuloplasty as a palliative procedure in tetralogy of fallot
  78. Balloon pulmonary valvuloplasty for palliation of tetralogy of fallot